The Global Insulin Pump Market with Focus on the United States: Industry Analysis & Outlook (2018-2022) - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Jan 10, 2019--The “Global Insulin Pump Market with Focus on United States: Industry Analysis & Outlook (2018-2022)” report has been added to ResearchAndMarkets.com’s offering.
The global insulin pump market is expected to grow significantly in future due to increasing diabetic population, ageing population and obesity rates. Rise in the global disposable income and healthcare expenditure by the households would push the market in positive direction.
In recent years, introduction of patch pumps in the market and increasing adoption of insulin pumps by the diabetic patients helped the market to flourish. Although, stringent legal norms and high cost of treatments could turn out to be a challenge for the market players.
In the U.S., insulin pump market is expected to rise in future. In 2017, the type 1 insulin pump users held the highest share in the U.S. insulin pump market. The insulin pump users would gradually grow in the region due to higher prevalence of diabetes among the population.
In terms of competitive landscape, the major players in the insulin pump market are Medtronic, Roche, Tandem Diabetes Care and Insulet Corporation. In 2017, Medtronic dominated the global insulin pump market in terms of revenue as well as patient share. Medtronic has been focusing on increasing production so as to progress in the global insulin pump market where the market is highly competitive.
Growth DriversAcceleration of Ageing Population Increasing Obesity Rates Longer Life Expectancy at Birth Increasing Disposable Income Rising Healthcare Expenditure The U.S. Diabetic Population Forecast
Key TrendsAdoption of Insulin Pumps Introduction of Patch Pumps
ChallengesStringent Legal Norms High Cost and Alternative Treatments
2. Global Insulin Pump Market
3. The U.S. Insulin Pump Market
4. Market Dynamics
5. Competitive Landscape
6. Company ProfilesInsulet Corporation Medtronic Roche Tandem Diabetes Care
For more information about this report visit https://www.researchandmarkets.com/research/xg6gv2/the_global?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20190110005261/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Diabetes Devices,Infusions and Injectables
INDUSTRY KEYWORD: HEALTH MEDICAL DEVICES DIABETES
SOURCE: Research and Markets
Copyright Business Wire 2019.
PUB: 01/10/2019 05:39 AM/DISC: 01/10/2019 05:39 AM